Keyphrases
Tumor Heterogeneity
77%
Estrogen Receptor 1 (ESR1)
76%
Whole Exome Sequencing
70%
Human Epidermal Growth Factor Receptor 2 (HER2)
56%
Overexpression
49%
Next-generation Sequencing
47%
PIK3CA mutation
44%
Breast Cancer
42%
Tumor
42%
Endocrine Therapy
36%
Human Cancer
36%
Bone Mineral Density
36%
Tumor Development
33%
Genetic Interaction
33%
Breast Cancer Susceptibility Gene 1 (BRCA1)
33%
BRCA2
33%
Mammary Tumor
33%
Trp53
33%
Phenotype Heterogeneity
33%
Genome Stability
33%
Clonal Origin
33%
Treatment Standards
33%
Ovarian Cancer G-protein-coupled Receptor 1
33%
N-Myc
33%
Homeostasis
33%
Mineralization Defect
33%
Downregulated Genes
33%
TP53 Alterations
33%
Cell-derived
33%
Liquid Biopsy
33%
Primary Breast Cancer
33%
Circulating Tumor DNA (ctDNA)
33%
Breast Cancer Model
33%
P Domain
33%
Plasma Tumor DNA
33%
Proton
33%
Notch1
33%
Centrosome
33%
Breast Cell Lines
33%
High Dose
33%
Free Radicals
33%
Metabolic Acidosis
33%
Limited Quantity
33%
Poly(ethylene glycol) Diacrylate (PEGDA)
33%
DNA Samples
33%
1,25(OH)2D3
33%
Neonatal Mice
33%
Oncogenic Properties
33%
Breast Cancer Mortality
33%
Azides
33%
Biochemistry, Genetics and Molecular Biology
Genetics
100%
Exome Sequencing
77%
Carcinogenesis
72%
Estrogen Receptor
69%
Estrogen Receptor Alpha
66%
Next Generation Sequencing
61%
Anchorage Independent Growth
50%
Cell Proliferation
50%
Blood Plasma
38%
Mitogen-Activated Protein Kinase
36%
Mediator
36%
Gene Interaction
33%
PALB2
33%
BRCA1
33%
Cell Contact
33%
Cell Mutant
33%
Stable Transfection
33%
Centrosome
33%
N-Myc
33%
Genome Instability
33%
Gene Targeting
33%
Fibroblast Growth Factor 23
33%
Janus Kinase
33%
P53
33%
Gamma Secretase
33%
Cancer Incidence
33%
Overall Survival
33%
Epidermal Growth Factor Receptor
33%
Clinical Trial
33%
Missense Mutation
33%
Homeostasis
33%
Dynamics
33%
Amplicon Sequencing
33%
Cancer Model
33%
Bone Density
33%
Mineralization
33%
Fibronectin
33%
Germ Cell
28%
Germline
28%
Somatic Mutation
27%
BRCA2
22%
Tumor Suppressor Gene
21%
Tumor Gene
21%
Genomics
21%
Genome Editing
20%
Droplet Digital Polymerase Chain Reaction
19%
Drug Sensitivity
16%
Agar
16%
Epigenetic Therapy
16%
Colony Formation
16%
Medicine and Dentistry
Neoplasm
69%
Bone Density
66%
Breast Cancer
50%
Malignant Neoplasm
41%
Metabolic Acidosis
35%
G Protein Coupled Receptor
33%
Exome Sequencing
33%
Breast Carcinoma
33%
Breast Cell Line
33%
Circulating Tumor DNA
33%
Drug Megadose
33%
Carcinogenesis
33%
Cell-Free DNA
33%
Mineralization
33%
Receptor
33%
Ductal Carcinoma
33%
Fibroblast Growth Factor 23
33%
Cell Line
33%
Tumour Heterogeneity
33%
Ovarian Cancer
33%
Liquid Biopsy
33%
Clinical Trial
22%
Stable Transfection
22%
In Vitro
22%
Cancer
19%
Solid Organ Transplantation
16%
Oncology
16%
Vitamin D Receptor
16%
Prenatal Screening
16%
Biological Marker
16%
Clinical Medicine
16%
Clinical Oncology
16%
Primary Tumor
16%
Diseases
16%
Tibia
11%
Osteoblast
11%
Drug Sensitivity
11%
Paclitaxel
11%
Agar
11%
Colony Formation
11%
Cancer Cell
11%
Cell Proliferation
11%
Mediator
11%
Cooperation
11%
Epithelial Cell Line
11%
Anticarcinogen
11%
Metastasis Potential
11%
Targeted Therapy
11%
Oncogene
11%
Somatic Cell
11%
